Review articles - page 17

Insulin resistance as a novel therapeutic target in patients with chronic kidney disease treated with dialysis

Piotr Wesołowski, Marek Saracyn, Zbigniew Nowak, Zofia Wańkowicz

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 54-58 / DOI: 10.20452/pamw.883

Psychological aspects of dialysis: does cognitive appraisal determine the overall outcome?

Krzysztof Laudański, Zbigniew Nowak, Zofia Wańkowicz

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 49-53 / DOI: 10.20452/pamw.881

Syncope: diagnosis and management according to the 2009 guidelines of the European Society of Cardiology

Richard Sutton, David Benditt, Michele Brignole, Angel Moya

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 42-48 / DOI: 10.20452/pamw.879

Hemoglobin A1c for the diagnosis of diabetes. Practical considerations

William H. Herman, Stefan S. Fajans

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 37-41 / DOI: 10.20452/pamw.877

Reappraisal of the European guidelines on hypertension management. The European Society of Hypertension Task Force document: a short review

Robert Fagard

Pol Arch Intern Med. 2010, Vol. 120, No. 1-2: 31-36 / DOI: 10.20452/pamw.875

Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment

Agnieszka Próchnicka, Anna Olszowska, Daniel Baczyński, Grzegorz Żelichowski, Zofia Wańkowicz

Pol Arch Intern Med. 2009, Vol. 119, No. 12: 815-819 / DOI: 10.20452/pamw.851

Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease

Zofia Wańkowicz

Pol Arch Intern Med. 2009, Vol. 119, No. 12: 810-814 / DOI: 10.20452/pamw.849

Practical implications of the revised guidelines for inpatient glycemic control

Jodie Reider, Amy Donihi, Mary T. Korytkowski

Pol Arch Intern Med. 2009, Vol. 119, No. 12: 8001-809 / DOI: 10.20452/pamw.847

Persistent pain in the older adult. What should we do now in light of the 2009 American Geriatrics Society Clinical Practice Guideline?

James D. Katz, Tina Shah

Pol Arch Intern Med. 2009, Vol. 119, No. 12: 795-800 / DOI: 10.20452/pamw.845

The role of glucagon‑like peptide 1 in glucose homeostasis and in other aspects of human physiology

Edward Franek, Grzegorz Gajos, Janusz Gumprecht, Adam Krętowski, Barbara Zahorska‑Markiewicz, Maciej T. Małecki

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 743-751 / DOI: 10.20452/pamw.829

Diagnosis of early atherosclerotic lesions, and selected atherosclerotic risk factors, in patients with systemic lupus erythematosus

Katarzyna Fischer, Marek Brzosko

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 736-742 / DOI: 10.20452/pamw.827

Clinical equivalence testing of inhaled bronchodilators

Parameswaran Nair, John Hanrahan, Frederick E. Hargreave

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 731-735 / DOI: 10.20452/pamw.825

Drip‑and‑ship for acute ST‑segment myocardial infarction. The pharmacoinvasive strategy for patients treated with fibrinolytic therapy

Shaun G. Goodman, Warren J. Cantor

Pol Arch Intern Med. 2009, Vol. 119, No. 11: 726-730 / DOI: 10.20452/pamw.823

Should we target HDL cholesterol level in lowering cardiovascular risk?

Peter P. Toth

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 667-672 / DOI: 10.20452/pamw.801

How to diagnose and treat work‑related asthma. Key messages for clinical practice from the American College of Chest Physicians Consensus Statement

Susan M. Tarlo, Gary M. Liss, Paul D. Blanc

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 660-666 / DOI: 10.20452/pamw.799

Seasonal and pandemic influenza vaccines for the elderly and other risk groups. A review of available data

Piotr Kramarz, Bruno Ciancio, Angus Nicoll

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 654-659 / DOI: 10.20452/pamw.797

Do α‑reductase inhibitors prevent prostate cancer? 2008 Practice Guideline from the American Society of Clinical Oncology and American Urological Association

David Thüer, David Pfister, Robin Epplen, Bernhard Brehmer, Axel Heidenreich

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 648-653 / DOI: 10.20452/pamw.795

Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta‑analyses

Peter Gross, Holger Schirutschke, Kerstin Barnett

Pol Arch Intern Med. 2009, Vol. 119, No. 10: 644-647 / DOI: 10.20452/pamw.793

Systemic lupus erythematosus and myasthenia gravis

Antoni Hrycek

Pol Arch Intern Med. 2009, Vol. 119, No. 9: 582-585 / DOI: 10.20452/pamw.773

The Terri Schiavo saga: ethical and legal aspects and implications for clinicians

Paul S. Mueller

Pol Arch Intern Med. 2009, Vol. 119, No. 9: 574-581 / DOI: 10.20452/pamw.771

previousof 23next

Impact Factor 2023

3.8

Quartile in the category

Q1

IC value for 2022

217.18

Ministry of Education and Science score

200
Average times from:
submission to 1st decision, 2 days
submission to first reviews, 24 days
acceptance to online first publication, 5 days
acceptance to final publication, 45 days

Current manuscript acceptance rate: 27%
The journal is co-financed from the state budget under the "Development of scientific journals" program of the Ministry of Education and Science in the years 2022-2024. Read more